Trial intelligence / Profile preview

Effect of Aliskiren on Muscle Sympathetic Nerve Activity in hypertensive patients with chronic kidney disease

2007-005401-22Phase 3Active

Sponsor
University Medical Center Utrecht
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of aliskiren in hypertension (HTN) and chronic kidney disease (CKD), sponsored by University Medical Center Utrecht. Primary endpoint: Effect of Aliskiren on MSNA. Started Oct 2007; status: active.

02

Drugs

aliskiren
03

Conditions

hypertension (HTN)chronic kidney disease (CKD)

Beyond the preview

Go deeper on 2007-005401-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005401-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call